A modeling device for mitral regurgitation and its application

Through high-frequency electrocoagulation equipment and ultrasonic-guided fixed-point electrocautery technology, the problem of large surgical damage and inability to observe in real time of mitral valve regurgitation modeling device is solved, and a minimally invasive, stable and easy-to-operate small animal model is provided to simulate The capacity overload characteristics caused by clinical valve regurgitation provide a new model animal for translational medicine research.

CN118058865BActive Publication Date: 2024-12-03ZHONGSHAN HOSPITAL FUDAN UNIV
View PDF 2 Cites 0 Cited by

Patent Information

Application Number
CN202410207130.6
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2024-02-26
Publication Date
2024-12-03
Estimated Expiration
2044-02-26

AI Technical Summary

Technical Problem

The existing mitral valve regurgitation modeling device has large surgical damage and the inability to observe mitral valve regurgitation in real time, resulting in low survival rate and stability of the model, especially in mouse models, almost no reports.

Method used

High-frequency electrocoagulation equipment combined with high-frequency ultrasound guidance, and fixed-point electrocautery is performed on small animals through puncture to achieve modeling of mitral valve regurgitation. The insulated coating of the puncture needle and the ultrasound system are used to observe the regurgitation situation in real time. Reduce damage to other organs.

Benefits of technology

The minimally invasive, easy to operate and high stability modeling of mitral valve regurgitation in small animals is realized, and the capacity overload characteristics caused by clinical valve regurgitation is simulated, providing a new and easy-to-promote model animal for translational medicine research.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118058865B_ABST
    Figure CN118058865B_ABST
Patent Text Reader

Abstract

The present invention belongs to the field of biomedicine technology. The present invention discloses a modeling device for mitral regurgitation and its application, including an insulated puncture needle with an uncoated tip, an electrocoagulation pen for fixing the puncture needle, the other end of the electrocoagulation pen is connected to a high-frequency electrocoagulation system, and a foot-operated electrocoagulation controller for conveniently controlling the discharge of the electrocoagulation pen. Under the guidance of high-frequency ultrasound, the puncture needle is used to puncture the heart, and the needle tip is moved to the mitral valve orifice. The foot-operated electrocoagulation controller is used to instantly release current to burn the mitral valve and cause mitral regurgitation, thereby increasing cardiac capacity overload and causing eccentric hypertrophy. The shortcomings of the current mitral regurgitation modeling, such as large damage, high mortality, poor repeatability and inability to observe in real time, are solved. An easy-to-operate device is provided for cardiac capacity overload modeling, and a new model animal that is minimally invasive, has good repeatability, is easy to promote and is close to clinical lesions is provided for translational medical research.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the field of biomedical technology, and more specifically, to a mitral valve regurgitation modeling device and application thereof. Background Art

[0002] Volume overload is an important pathogenesis of cardiovascular disease. However, related research is limited by the lack of suitable small animal models. Mitral regurgitation lesions in the heart are manifested as valvular regurgitation with insufficient closure. The heart is subjected to volume overload, causing eccentric cardiac hypertrophy, which can be long-term subclinical and has progressive and degenerative characteristics. Previously, there have been a small number of reports on mouse models of volume overload cardiac remodeling. The arteriovenous fistula model is relatively commonly used. Although this model can show the characteristics of cardiac decompensation caused by valvular leakage, it does not have the most typical diastolic "regurgitation" characteristics of valvular disease, and non-characteristic right ventricular hypertrophy occurs clinically. It was not until 2020 that reports of mitral regurgitation models in small animals began to appear. The models mainly include rat models with open-chest puncture of the mitral valve and mouse models with rapid shearing of mitral chordae tendineae. Although this type of mitral valve model can better simulate the volume overload characteristics caused by clinical valvular disease, it is difficult to replicate the model due to its large surgical injury and high mortality rate, and the inability to observe the mitral valve regurgitation in real time, which greatly reduces the survival rate and stability of the model. In the following three years, there have been almost no reports on the use of this model by other research groups, especially mouse models. It can be concluded that there have been no reports on any minimally invasive, convenient and stably constructed small animal models for a long time.

[0003] In view of this, the present invention provides a mitral regurgitation modeling device and application thereof. Summary of the invention

[0004] In order to overcome the problems in the prior art, the present invention proposes a mitral regurgitation modeling device and application thereof to solve the problem that the existing mitral regurgitation modeling has great damage and cannot be observed in real time.

[0005] According to one aspect of the present invention, a modeling device for mitral valve regurgitation is provided, comprising:

[0006] Puncture needle, used for puncturing the chest cavity and heart of small animals;

[0007] Electrocoagulation pen, fixed puncture needle and high-frequency electrocoagulation equipment;

[0008] Foot control switch, which controls the discharge of high-frequency electrocoagulation equipment by pressing;

[0009] High frequency electrocoagulation equipment, regulating discharge power.

[0010] Under the guidance of high-frequency ultrasound, the puncture needle is used to perform chest puncture on small animals. When the needle tip moves to the mitral valve orifice, the high-frequency electrocoagulation device is controlled to discharge through a foot-operated control switch, so that the electrocoagulation pen performs targeted burns on the mitral valve, resulting in mitral valve insufficiency causing reflux, thereby increasing cardiac capacity overload and causing eccentric hypertrophy.

[0011] As a preferred solution of the present invention, the puncture needle comprises an insulating cylindrical needle body and a needle tip and a conductive column arranged at both ends of the needle body; the conductive column is a conductive cylinder of uniform specifications.

[0012] As a preferred solution of the present invention, the needle tip comprises a needle tip end for puncture, and the needle tip end is fixed on the needle body through a needle tip slope.

[0013] As a preferred solution of the present invention, the electrocoagulation pen includes an electrocoagulation pen body and a spiral fixing ring and a connecting wire arranged on the electrocoagulation pen body, and a plastic shell is connected to the outside of the spiral fixing ring and the electrocoagulation pen body, and the connecting wire passes through the plastic shell to connect to the high-frequency electrocoagulation device.

[0014] As a preferred solution of the present invention, the spiral fixing ring can fix the conductive columns of the puncture needles of different models.

[0015] As a preferred solution of the present invention, the high-frequency electrocoagulation device is built with a socket adapted for the electrocoagulation pen and the foot control switch, a power adjustment switch and a control panel;

[0016] Adjust the appropriate electrocoagulation power according to actual needs.

[0017] According to another aspect of the present invention, a method for modeling mitral regurgitation is provided, based on the implementation of the device for modeling mitral regurgitation, comprising the following steps:

[0018] Step 1: After pre-treatment anesthesia, fix the mouse on the ultrasonic system heating plate in a supine position, apply conductive paste to the ends of the mouse's limbs and place them close to the conductive area of ​​the heating plate, and continue anesthesia;

[0019] Step 2, performing hair removal to expose the chest skin of the small animal, and performing medical disinfection, and puncturing the small animal with the needle tip (1-1) of the puncture needle (1) between the 4th and 5th ribs on the left side of the mouse under the ultrasonic probe;

[0020] Step 3, observe the needle insertion situation on the long axis section of the ultrasound B-type image. When the puncture needle moves to the mitral valve orifice, adjust the puncture needle tip to face the bevel downward, and press the foot control switch (3) to discharge instantly, and perform fixed-point electrocautery on the valve that the needle tip (1-1) is in contact with, for no more than 3 seconds;

[0021] Step 4, convert the ultrasound to blood flow Doppler mode and observe the regurgitation of the mitral valve;

[0022] Step 5: When the reflux reaches the expected value, withdraw the puncture needle, disinfect the puncture site with iodine, and place the patient on a warming pad to wake up.

[0023] As a preferred embodiment of the present invention, the medical disinfection treatment comprises:

[0024] The animals were dehaired, the chest skin of the mice was exposed, and then disinfected with iodine tincture.

[0025] As a preferred embodiment of the present invention, the specific steps of the puncture treatment are:

[0026] Insert the needle with the bevel of the needle tip facing upward at an angle of about 30 degrees to the coronal plane of the mouse, and penetrate the mouse skin, thorax and myocardium in sequence.

[0027] The technical effects and advantages of a mitral valve regurgitation modeling device and its application in the present invention are as follows:

[0028] Taking advantage of the characteristics of small animals, the high-frequency electrocoagulation system combined with the high-frequency ultrasound system can be used to guide the mitral valve of small animals to perform fixed-point electrocautery, which can observe the degree of mitral valve regurgitation of small animals in real time, dynamically and safely throughout the whole process. The beveled needle tip and insulating coated needle body of the puncture needle also greatly reduce the damage to other organs and other parts of the heart during the modeling process, providing a simple and easy-to-operate device for modeling cardiac volume overload, and providing a new, minimally invasive, easy-to-promote and clinically lesion model animal for translational medical research. BRIEF DESCRIPTION OF THE DRAWINGS

[0029] Figure 1 It is a schematic diagram of a top view structure of a modeling device provided by the present invention;

[0030] Figure 2 This is a structural front view of the puncture needle part provided by the present invention;

[0031] Figure 3 is a top view of the structure of the puncture needle part provided by the present invention;

[0032] Figure 4 is a structural cross-sectional view of the puncture needle portion provided by the present invention;

[0033] Figure 5 It is a structural schematic diagram of the electrocoagulation pen part provided by the present invention;

[0034] Figure 6 It is a puncture image of a mouse collected in the B-mode ultrasound image mode of the present invention;

[0035] Figure 7The mitral regurgitation images of mice collected by the present invention under ultrasound color Doppler and pulsed Doppler modes before and after modeling;

[0036] Figure 8 The ultrasound B-mode images and the general appearance images of the mitral valve itself after sham operation (Sham) and mitral regurgitation surgery (MR) of mice with mitral regurgitation collected by the present invention 16 weeks later;

[0037] Fig. 9 This is an echocardiogram of a mouse with mitral regurgitation collected by the present invention after 16 weeks;

[0038] Fig.10 The changes in heart failure markers collected by the present invention after 16 weeks of mitral regurgitation in mice;

[0039] Fig.11 This is a cardiac pathological characteristic diagram collected by the present invention after 16 weeks of mitral valve regurgitation in mice.

[0040] In the figure: 1 is a puncture needle, 2 is an electrocoagulation pen, 3 is a foot control switch, 4 is a high-frequency electrocoagulation device, 1-1 is a needle tip, 1-2 is a needle body, 1-3 is a conductive column, 1-1-1 is a needle tip, 1-1-2 is a needle tip slope, 1-1-3 is a back of the needle tip, 1-2-1 is a puncture needle body, and 1-2-2 is an insulating coating;

[0041] 2-1 is a spiral fixing ring, 2-2 is the main body of the electrocoagulation pen, 2-3 is a plastic shell, and 2-4 is a connecting line. DETAILED DESCRIPTION

[0042] The following will be combined with the drawings in the embodiments of the present invention to clearly and completely describe the technical solutions in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0043] Example 1

[0044] The modeling device for mitral regurgitation described in this embodiment, taking mice as an example, comprises:

[0045] like Figure 1As shown, the puncture needle 1 is composed of a needle tip 1-1, a needle body 1-2 and a conductive column 1-3 at the end, which can be connected to the electrocoagulation pen 2 through the conductive column 1-3; the electrocoagulation pen 2 has a spiral fixing ring 2-1 at the front end, which can fix the conductive column 1-3 of the puncture needle 1 by rotation, and the other end is connected to the socket of the high-frequency electrocoagulation device 4 through a plug; the foot control switch 3 can control the high-frequency electrocoagulation device 4 to discharge when pressed, and can stop discharging after releasing, and is connected to the socket of the high-frequency electrocoagulation device 4 through a plug; the high-frequency electrocoagulation device 4 contains a socket connected to the electrocoagulation pen 2 and the foot control switch 3, a power adjustment knob and a control panel, and high-frequency currents of different powers can be released by rotating the knob and pressing the control switch.

[0046] like Figure 2-4 As shown, the puncture needle 1 includes: a needle tip 1-1, a needle body 1-2 and a terminal conductive column 1-3. The needle tip 1-1 is a non-coated inclined cylindrical shape, which is divided into a needle tip 1-1-1 and a needle tip slope 1-1-2; the needle body 1-2 is a cylindrical body with an insulating coating, which is divided into a puncture needle body 1-2-1 and an insulating coating 1-2-2, which reduces the damage to other organs and tissues during the electrocautery process; the conductive column 1-3 is a conductive cylinder that can be matched with the spiral fixing ring 2-1 of the electrocoagulation pen. The specifications of the conductive columns of different types of puncture needles are consistent. When the size of the small animal is different, different types of puncture needles can be replaced to reduce the damage to other organs and tissues during the modeling process without affecting the degree of reflux.

[0047] like Figure 5 As shown, the electrocoagulation pen 2 comprises: a spiral fixing ring 2-1, an electrocoagulation pen body 2-2, a plastic shell 2-3 and a connecting line 2-4. The front end of the electrocoagulation pen 2 can be narrowed by rotating the spiral fixing ring 2-1 to fix the puncture needle conductive column 1-3.

[0048] Example 2

[0049] For the undisclosed parts of this embodiment, please refer to Example 1. The present invention also provides a modeling method for mitral regurgitation; the method comprises the following steps:

[0050] Step 1, after the mouse is pre-anesthetized by inhalation of isoflurane, it is quickly fixed on the heating plate of the ultrasound system in a supine position, and the ends of the mouse's limbs are coated with conductive paste and placed close to the conductive area of ​​the heating plate, and anesthesia is maintained by continuous inhalation of isoflurane gas containing 1.5% to 2% by volume;

[0051] Step 2: Use depilatory cream to remove hair, expose the mouse chest skin, and disinfect it with iodine tincture. Under the ultrasound probe, insert the 30G puncture needle 1 between the 4th and 5th ribs on the left side of the mouse with the needle tip bevel facing upward and at an angle of about 30 degrees to the coronal plane of the mouse, and pierce the mouse skin, thorax, and myocardium in turn. Figure 6 As shown, the red arrow in the figure indicates the puncture needle;

[0052] Step 3, in the ultrasound B-mode image mode, observe the insertion of the puncture needle 1 in the long axis section, and when the puncture needle 1 moves to the mitral valve orifice, adjust the puncture needle 1 so that the bevel of the needle tip faces downward, and discharge instantly by pressing the foot control switch 3 to perform electrocautery on the valve against which the needle tip is close, for a duration of no more than 2 seconds;

[0053] Step 4: Switch the ultrasound to blood flow Doppler mode and observe the mitral valve regurgitation, such as Figure 7 As shown, the mitral valve blood flow of mice with successful valve puncture modeling showed obvious reverse blood flow (blue) in color Doppler mode and obvious reverse blood flow in pulsed Doppler mode;

[0054] Step 5: When the degree of reflux reaches the expected level, quickly withdraw the puncture needle, disinfect the puncture site with iodine, and place the mouse on a warming pad to wait for awakening.

[0055] According to the experimental needs, the mice were divided into a sham operation group without mitral regurgitation and a mitral regurgitation group with regurgitation. In the sham operation group, no discharge was performed when the puncture needle reached the mitral valve orifice, and the rest of the operations were the same as those in the mitral regurgitation group. In addition to the above observations of immediate postoperative valvular regurgitation, ultrasound examinations of the mitral valve and left ventricle of the mice were performed at week 16, and it was found that the mitral valve of the mice in the mitral regurgitation group was significantly thickened and damaged, such as Figure 8 As shown in the figure, the left ventricular cavity is significantly enlarged and the cardiac function is reduced, but the ventricular wall thickness is not significantly thickened. Fig. 9 As shown, it is consistent with the obvious characteristics of volume overload eccentric hypertrophy. At the 16th week after surgery, the heart was collected to measure heart failure markers and conduct pathological observations. It was found that the gene levels of ANP (atrial natriuretic peptide) and BNP (brain natriuretic peptide) (Nppa and Nppb) were significantly increased, the size of the heart was significantly increased, and the cross-sectional area of ​​myocardial cells and cardiac fibrosis increased. Figure 10-11 shown.

[0056] In summary, the present invention utilizes the characteristics of small animals, and uses an electrocoagulation device and an insulated puncture needle under ultrasound guidance to perform fixed-point electrocautery on the mitral valve of small animals, causing mitral regurgitation, so as to simulate patients with volume overload induced by valvular regurgitation in clinical practice. During the modeling process, the ultrasound system is used to visualize and the specially treated puncture needle is used for fixed-point electrocautery, which solves the problem that the current mitral regurgitation modeling cannot be observed in real time and has great damage, and provides a simple and easy-to-operate device for modeling cardiac volume overload, and also provides a new, minimally invasive, stable, easy-to-promote, and clinically lesion-close model animal for translational medical research.

[0057] The above is only a specific embodiment of the present invention, but the protection scope of the present invention is not limited thereto. Any person skilled in the art can easily think of changes or substitutions within the technical scope disclosed by the present invention, which should be included in the protection scope of the present invention. Therefore, the protection scope of the present invention should be based on the protection scope of the claims.

[0058] Finally: The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. Any modifications, equivalent substitutions, improvements, etc. made within the spirit and principles of the present invention should be included in the protection scope of the present invention.

Claims

1. A modeling device for mitral regurgitation, characterized in that: include: A puncture needle (1) is used for puncturing the chest cavity and heart of a small animal; The puncture needle (1) comprises an insulating cylindrical needle body (1-2) and a needle tip (1-1) and a conductive column (1-3) arranged at both ends of the needle body (1-2); the conductive column (1-3) is a conductive cylinder of uniform specifications; the needle tip (1-1) comprises a needle tip (1-1-1) for puncture; the needle tip (1-1-1) is fixed to the needle body (1-2) via a needle tip slope (1-1-2); An electrocoagulation pen (2) fixes the puncture needle (1) and the high-frequency electrocoagulation device (4); A foot control switch (3) is used to control the discharge of the high-frequency electrocoagulation device (4) by pressing it; High frequency electrocoagulation equipment (4), regulating discharge power. Under the guidance of high-frequency ultrasound, the puncture needle (1) is used to perform thoracic puncture on a small animal. When the needle tip moves to the mitral valve orifice, the high-frequency electrocoagulation device (4) is controlled to discharge through a foot-operated control switch (3), so that the electrocoagulation pen (2) performs a targeted burn on the mitral valve, resulting in mitral valve insufficiency and reflux.

2. A mitral regurgitation modeling device according to claim 1, characterized in that: The electrocoagulation pen (2) comprises an electrocoagulation pen body (2-2), a spiral fixing ring (2-1) and a connecting line (2-4) arranged on the electrocoagulation pen body (2-2), and a plastic shell (2-3) is connected outside the spiral fixing ring (2-1) and the electrocoagulation pen body (2-2), and the connecting line (2-4) passes through the plastic shell (2-3) to connect to a high-frequency electrocoagulation device (4).

3. A mitral regurgitation modeling device according to claim 1, characterized in that: The spiral fixing ring (2-1) fixes the conductive posts (1-3) of puncture needles (1) of different models.

4. A mitral regurgitation modeling device according to claim 1, characterized in that: The high-frequency electrocoagulation device (4) is built with a socket adapted for the electrocoagulation pen and the foot control switch, a power adjustment switch and a control panel; Adjust the appropriate electrocoagulation power according to actual needs.

Citation Information

Patent Citations

  • Trans-atrial pathway atrioventricular valve regurgitation animal modeling device and method

    CN103300938A

  • Method for establishing mouse model of cardiac volume overload

    CN108553195A